Zennya Health valuation, funding and investors
Zennya Health works in primary care delivery services, based in Makati, Philippines. Founded in 2015, it has about 109 employees.
Makati Seed
VALUATION · TODAY
$16.2M +0% after Seed
Range $2.69M – $97.4M · Grade DTODAY
+12 MO
$20.0M
$40.0M
$60.0M
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Seed $1.00M
ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then
HEADCOUNT · TODAY110 employees
+9%6m growth
+6%1y growth
+25%2y growth
50
100
150
Data from Jan 2021
Predicted in 1 yr $16.2M +0% vs today
Predicted next raise – no prediction
Winding-down probability 0%
- Last round
- Seed · $1.00M · May 2021
- Valuation at last round
- –
- Headcount
- 110 · flat
- Grade
- D
- Founded
- 2015
Zennya Health valuation today
VCMC values Zennya Health at $16.2M today, with a range of $2.69M to $97.4M and a grade of D. It is valued on its headcount and industry.
Valuation by date (144 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2015 | $2.08M | $0.76M – $5.72M | $2.18M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2015 | $2.09M | $0.76M – $5.74M | $2.19M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2015 | $2.10M | $0.76M – $5.76M | $2.20M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2015 | $2.11M | $0.77M – $5.79M | $2.21M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2015 | $2.11M | $0.77M – $5.81M | $2.22M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2015 | $2.12M | $0.77M – $5.83M | $2.22M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2015 | $2.13M | $0.78M – $5.85M | $2.23M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2015 | $2.14M | $0.78M – $5.88M | $2.29M (+7%) | before first round | – | unknown | D | 0% |
| 1 Sep 2015 | $2.15M | $0.78M – $5.90M | $2.35M (+10%) | before first round | – | unknown | D | 0% |
| 1 Oct 2015 | $2.16M | $0.79M – $5.92M | $2.42M (+12%) | before first round | – | unknown | D | 0% |
| 1 Nov 2015 | $2.17M | $0.79M – $5.95M | $2.48M (+15%) | before first round | – | unknown | D | 0% |
| 1 Dec 2015 | $2.17M | $0.79M – $5.97M | $2.55M (+17%) | before first round | – | unknown | D | 0% |
| 1 Jan 2016 | $2.18M | $0.79M – $5.99M | $2.62M (+20%) | before first round | – | unknown | D | 0% |
| 1 Feb 2016 | $2.19M | $0.80M – $6.02M | $2.69M (+23%) | before first round | – | unknown | D | 0% |
| 1 Mar 2016 | $2.20M | $0.80M – $6.04M | $2.75M (+25%) | before first round | – | unknown | D | 0% |
| 1 Apr 2016 | $2.21M | $0.80M – $6.06M | $2.83M (+28%) | before first round | – | unknown | D | 0% |
| 1 May 2016 | $2.22M | $0.81M – $6.09M | $2.90M (+31%) | before first round | – | unknown | D | 0% |
| 1 Jun 2016 | $2.23M | $0.81M – $6.11M | $2.98M (+34%) | before first round | – | unknown | D | 0% |
| 1 Jul 2016 | $2.23M | $0.81M – $6.14M | $3.06M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2016 | $2.29M | $0.83M – $6.30M | $3.14M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2016 | $2.36M | $0.86M – $6.47M | $3.23M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2016 | $2.42M | $0.88M – $6.64M | $3.31M (+37%) | before first round | – | unknown | D | 0% |
| 1 Nov 2016 | $2.48M | $0.90M – $6.82M | $3.40M (+37%) | before first round | – | unknown | D | 0% |
| 1 Dec 2016 | $2.55M | $0.93M – $7.00M | $3.49M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jan 2017 | $2.62M | $0.95M – $7.19M | $3.59M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2017 | $2.69M | $0.98M – $7.38M | $3.68M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2017 | $2.75M | $1.00M – $7.56M | $3.77M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2017 | $2.83M | $1.03M – $7.77M | $3.88M (+37%) | before first round | – | unknown | D | 0% |
| 1 May 2017 | $2.90M | $1.06M – $7.97M | $3.98M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jun 2017 | $2.98M | $1.08M – $8.19M | $4.09M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jul 2017 | $3.06M | $1.11M – $8.40M | $4.19M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2017 | $3.14M | $1.14M – $8.63M | $4.31M (+37%) | before first round | – | unknown | D | 0% |
| 1 Sep 2017 | $3.23M | $1.17M – $8.86M | $4.42M (+37%) | before first round | – | unknown | D | 0% |
| 1 Oct 2017 | $3.31M | $1.21M – $9.10M | $4.54M (+37%) | before first round | – | unknown | D | 0% |
| 1 Nov 2017 | $3.40M | $1.24M – $9.34M | $4.66M (+37%) | before first round | – | unknown | D | 0% |
| 1 Dec 2017 | $3.49M | $1.27M – $9.59M | $4.79M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jan 2018 | $3.59M | $1.31M – $9.85M | $4.92M (+37%) | before first round | – | unknown | D | 0% |
| 1 Feb 2018 | $3.68M | $1.34M – $10.1M | $5.05M (+37%) | before first round | – | unknown | D | 0% |
| 1 Mar 2018 | $3.77M | $1.37M – $10.4M | $5.17M (+37%) | before first round | – | unknown | D | 0% |
| 1 Apr 2018 | $3.88M | $1.41M – $10.6M | $5.31M (+37%) | before first round | – | unknown | D | 0% |
| 1 May 2018 | $3.98M | $1.45M – $10.9M | $5.45M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jun 2018 | $4.09M | $1.49M – $11.2M | $5.60M (+37%) | before first round | – | unknown | D | 0% |
| 1 Jul 2018 | $4.19M | $1.53M – $11.5M | $5.75M (+37%) | before first round | – | unknown | D | 0% |
| 1 Aug 2018 | $4.31M | $1.57M – $11.8M | $5.81M (+35%) | before first round | – | unknown | D | 0% |
| 1 Sep 2018 | $4.42M | $1.61M – $12.2M | $5.86M (+32%) | before first round | – | unknown | D | 0% |
| 1 Oct 2018 | $4.54M | $1.65M – $12.5M | $5.91M (+30%) | before first round | – | unknown | D | 0% |
| 1 Nov 2018 | $4.66M | $1.70M – $12.8M | $5.97M (+28%) | before first round | – | unknown | D | 0% |
| 1 Dec 2018 | $4.79M | $1.74M – $13.1M | $6.02M (+26%) | before first round | – | unknown | D | 0% |
| 1 Jan 2019 | $4.92M | $1.79M – $13.5M | $6.08M (+24%) | before first round | – | unknown | D | 0% |
| 1 Feb 2019 | $5.05M | $1.84M – $13.9M | $6.13M (+21%) | before first round | – | unknown | D | 0% |
| 1 Mar 2019 | $5.17M | $1.88M – $14.2M | $6.18M (+19%) | before first round | – | unknown | D | 0% |
| 1 Apr 2019 | $5.31M | $1.93M – $14.6M | $6.24M (+17%) | before first round | – | unknown | D | 0% |
| 1 May 2019 | $5.45M | $1.99M – $15.0M | $6.29M (+15%) | before first round | – | unknown | D | 0% |
| 1 Jun 2019 | $5.60M | $2.04M – $15.4M | $6.35M (+13%) | before first round | – | unknown | D | 0% |
| 1 Jul 2019 | $5.75M | $2.09M – $15.8M | $6.41M (+11%) | before first round | – | unknown | D | 0% |
| 1 Aug 2019 | $5.81M | $2.11M – $16.0M | $6.47M (+11%) | before first round | – | unknown | D | 0% |
| 1 Sep 2019 | $5.86M | $2.13M – $16.1M | $6.53M (+11%) | before first round | – | unknown | D | 0% |
| 1 Oct 2019 | $5.91M | $2.15M – $16.2M | $6.58M (+11%) | before first round | – | unknown | D | 0% |
| 1 Nov 2019 | $5.97M | $2.17M – $16.4M | $6.65M (+11%) | before first round | – | unknown | D | 0% |
| 1 Dec 2019 | $6.02M | $2.19M – $16.5M | $6.70M (+11%) | before first round | – | unknown | D | 0% |
| 1 Jan 2020 | $6.08M | $2.21M – $16.7M | $6.77M (+11%) | before first round | – | unknown | D | 0% |
| 1 Feb 2020 | $6.13M | $2.23M – $16.8M | $6.83M (+11%) | before first round | – | unknown | D | 0% |
| 1 Mar 2020 | $6.18M | $2.25M – $17.0M | $6.89M (+11%) | before first round | – | unknown | D | 0% |
| 1 Apr 2020 | $6.24M | $2.27M – $17.1M | $6.95M (+11%) | before first round | – | unknown | D | 0% |
| 1 May 2020 | $6.30M | $2.29M – $17.3M | $7.01M (+11%) | before first round | – | unknown | D | 0% |
| 1 Jun 2020 | $6.35M | $2.31M – $17.5M | $7.08M (+11%) | before first round | – | unknown | D | 0% |
| 1 Jul 2020 | $6.41M | $2.33M – $17.6M | $7.14M (+11%) | before first round | – | unknown | D | 0% |
| 1 Aug 2020 | $6.47M | $2.36M – $17.8M | $7.20M (+11%) | before first round | – | unknown | D | 0% |
| 1 Sep 2020 | $6.53M | $2.38M – $17.9M | $7.27M (+11%) | before first round | – | unknown | D | 0% |
| 1 Oct 2020 | $6.59M | $2.40M – $18.1M | $7.34M (+11%) | before first round | – | unknown | D | 0% |
| 1 Nov 2020 | $6.65M | $2.42M – $18.3M | $7.40M (+11%) | before first round | – | unknown | D | 0% |
| 1 Dec 2020 | $6.71M | $2.44M – $18.4M | $7.47M (+11%) | before first round | – | unknown | D | 0% |
| 1 Jan 2021 | $7.99M | $2.91M – $22.0M | $8.66M (+8%) | before first round | 45 | unknown | D | 0% |
| 1 Feb 2021 | $8.07M | $2.94M – $22.2M | $8.68M (+8%) | before first round | 45 | unknown | D | 0% |
| 1 Mar 2021 | $8.13M | $2.96M – $22.3M | $8.69M (+7%) | before first round | 45 | unknown | D | 0% |
| 1 Apr 2021 | $8.21M | $2.99M – $22.5M | $8.71M (+6%) | before first round | 45 | flat | D | 0% |
| 1 May 2021 | $8.28M | $3.01M – $22.7M | $8.72M (+5%) | before first round | 45 | flat | D | 0% |
| 27 May 2021 | $4.84M | $3.17M – $14.7M | $9.66M (+100%) | after a round | 45 | flat | C | 0% |
| 1 Jun 2021 | $4.89M | $3.17M – $14.7M | $9.66M (+98%) | after a round | 45 | flat | C | 0% |
| 1 Jul 2021 | $5.17M | $3.17M – $14.7M | $9.66M (+87%) | after a round | 45 | flat | C | 0% |
| 1 Aug 2021 | $5.49M | $3.17M – $14.7M | $9.66M (+76%) | after a round | 45 | flat | C | 0% |
| 1 Sep 2021 | $5.82M | $3.17M – $14.7M | $9.66M (+66%) | after a round | 45 | flat | C | 0% |
| 1 Oct 2021 | $6.16M | $3.17M – $14.7M | $9.66M (+57%) | after a round | 45 | flat | C | 0% |
| 1 Nov 2021 | $6.53M | $3.17M – $14.7M | $9.66M (+48%) | after a round | 45 | flat | C | 0% |
| 1 Dec 2021 | $6.92M | $3.17M – $14.7M | $9.66M (+40%) | after a round | 45 | flat | C | 0% |
| 1 Jan 2022 | $7.33M | $3.17M – $14.7M | $9.66M (+32%) | after a round | 45 | flat | C | 0% |
| 1 Feb 2022 | $7.78M | $3.17M – $14.7M | $9.66M (+24%) | after a round | 45 | flat | C | 0% |
| 1 Mar 2022 | $8.63M | $3.39M – $15.7M | $10.3M (+20%) | after a round | 61 | growing | C | 0% |
| 1 Apr 2022 | $9.21M | $3.39M – $15.7M | $10.3M (+12%) | after a round | 61 | growing | C | 0% |
| 1 May 2022 | $9.80M | $3.39M – $15.7M | $10.3M (+5%) | after a round | 61 | growing | C | 0% |
| 1 Jun 2022 | $10.3M | $3.40M – $15.7M | $10.3M (0%) | after a round | 61 | growing | C | 0% |
| 1 Jul 2022 | $10.3M | $3.41M – $15.7M | $10.3M (0%) | after a round | 61 | growing | C | 0% |
| 1 Aug 2022 | $10.3M | $3.43M – $15.7M | $10.3M (0%) | after a round | 61 | growing | C | 0% |
| 1 Sep 2022 | $10.3M | $3.44M – $15.7M | $10.3M (0%) | after a round | 61 | growing | C | 0% |
| 1 Oct 2022 | $10.3M | $3.46M – $15.7M | $10.3M (0%) | after a round | 61 | growing | C | 0% |
| 1 Nov 2022 | $10.3M | $2.61M – $15.7M | $10.3M (0%) | after a round | 61 | unknown | C | 0% |
| 1 Dec 2022 | $10.3M | $2.49M – $15.7M | $10.3M (0%) | after a round | 61 | unknown | C | 0% |
| 1 Jan 2023 | $10.3M | $2.37M – $15.7M | $10.3M (0%) | after a round | 61 | unknown | C | 0% |
| 1 Feb 2023 | $10.3M | $2.25M – $15.7M | $10.3M (0%) | after a round | 61 | unknown | C | 0% |
| 1 Mar 2023 | $10.3M | $2.15M – $15.7M | $10.3M (0%) | after a round | 61 | unknown | C | 0% |
| 1 Apr 2023 | $10.3M | $2.04M – $15.7M | $10.3M (0%) | after a round | 61 | unknown | D | 0% |
| 1 May 2023 | $10.4M | $1.96M – $15.9M | $10.4M (0%) | after a round | 64 | flat | D | 0% |
| 1 Jun 2023 | $10.4M | $1.87M – $15.9M | $10.4M (0%) | after a round | 64 | flat | D | 0% |
| 1 Jul 2023 | $10.4M | $1.78M – $15.9M | $10.4M (-1%) | after a round | 64 | flat | D | 0% |
| 1 Aug 2023 | $10.4M | $1.69M – $15.9M | $10.3M (-2%) | after a round | 64 | flat | D | 0% |
| 1 Sep 2023 | $10.4M | $1.60M – $15.9M | $10.2M (-2%) | after a round | 64 | flat | D | 0% |
| 1 Oct 2023 | $10.7M | $1.75M – $16.3M | $10.5M (-2%) | after a round | 72 | up | D | 0% |
| 1 Nov 2023 | $10.7M | $1.67M – $16.3M | $10.4M (-3%) | after a round | 72 | up | D | 0% |
| 1 Dec 2023 | $10.7M | $1.60M – $16.3M | $10.4M (-3%) | after a round | 72 | up | D | 0% |
| 1 Jan 2024 | $10.7M | $1.53M – $16.3M | $10.3M (-4%) | after a round | 72 | up | D | 0% |
| 1 Feb 2024 | $10.7M | $1.47M – $16.3M | $10.3M (-4%) | after a round | 72 | up | D | 0% |
| 1 Mar 2024 | $10.9M | $1.43M – $16.6M | $10.5M (-3%) | after a round | 78 | up | D | 0% |
| 1 Apr 2024 | $10.9M | $1.37M – $16.6M | $10.5M (-4%) | after a round | 78 | up | D | 0% |
| 1 May 2024 | $10.9M | $1.31M – $16.6M | $10.5M (-4%) | after a round | 78 | up | D | 0% |
| 1 Jun 2024 | $10.9M | $1.27M – $16.6M | $10.4M (-4%) | after a round | 78 | up | D | 0% |
| 1 Jul 2024 | $11.2M | $3.24M – $17.1M | $11.2M (0%) | after a round | 89 | growing | C | 0% |
| 1 Aug 2024 | $11.2M | $3.17M – $17.0M | $11.2M (0%) | after a round | 88 | growing | C | 0% |
| 1 Sep 2024 | $11.2M | $3.10M – $17.0M | $11.2M (0%) | after a round | 88 | growing | C | 0% |
| 1 Oct 2024 | $11.2M | $3.04M – $17.0M | $11.2M (0%) | after a round | 88 | growing | C | 0% |
| 1 Nov 2024 | $11.3M | $2.99M – $17.2M | $11.3M (0%) | after a round | 91 | growing | C | 0% |
| 1 Dec 2024 | $11.2M | $1.00M – $17.1M | $11.2M (-1%) | after a round | 91 | up | D | 0% |
| 1 Jan 2025 | $11.3M | $0.96M – $17.2M | $11.3M (0%) | after a round | 92 | up | D | 0% |
| 1 Feb 2025 | $11.3M | $0.91M – $17.2M | $11.3M (0%) | after a round | 92 | up | D | 0% |
| 1 Mar 2025 | $11.3M | $0.88M – $17.2M | $11.2M (0%) | after a round | 92 | up | D | 0% |
| 1 Apr 2025 | $11.3M | $0.84M – $17.2M | $11.2M (0%) | after a round | 92 | up | D | 0% |
| 1 May 2025 | $11.1M | $0.80M – $16.8M | $10.8M (-2%) | after a round | 92 | up | D | 0% |
| 1 Jun 2025 | $11.0M | $0.89M – $16.8M | $10.8M (-2%) | after a round | 92 | up | D | 0% |
| 1 Jul 2025 | $11.0M | $0.85M – $16.8M | $10.8M (-2%) | after a round | 92 | up | D | 0% |
| 1 Aug 2025 | $21.1M | $4.13M – $92.1M | $21.1M (0%) | valued on company size | 104 | growing | D | 0% |
| 1 Sep 2025 | $18.7M | $2.81M – $92.1M | $18.7M (0%) | valued on company size | 104 | up | D | 0% |
| 1 Oct 2025 | $18.7M | $2.81M – $92.1M | $18.7M (0%) | valued on company size | 104 | up | D | 0% |
| 1 Nov 2025 | $18.7M | $2.81M – $92.1M | $18.7M (0%) | valued on company size | 104 | up | D | 0% |
| 1 Dec 2025 | $18.5M | $2.78M – $91.2M | $18.5M (0%) | valued on company size | 103 | up | D | 0% |
| 1 Jan 2026 | $18.5M | $2.78M – $91.2M | $18.5M (0%) | valued on company size | 103 | up | D | 0% |
| 1 Feb 2026 | $18.5M | $2.78M – $91.2M | $18.5M (0%) | valued on company size | 103 | up | D | 0% |
| 1 Mar 2026 | $18.5M | $2.78M – $91.2M | $18.5M (0%) | valued on company size | 103 | up | D | 0% |
| 1 Apr 2026 | $18.2M | $2.73M – $89.4M | $18.2M (0%) | valued on company size | 101 | up | D | 0% |
| 1 May 2026 | $18.4M | $2.76M – $90.3M | $18.4M (0%) | valued on company size | 102 | up | D | 0% |
| 1 Jun 2026 | $18.4M | $2.76M – $90.3M | $18.4M (0%) | valued on company size | 102 | up | D | 0% |
| 1 Jul 2026 | $18.4M | $2.76M – $90.3M | $18.4M (0%) | valued on company size | 102 | up | D | 0% |
| 1 Aug 2026 | $15.0M | $2.49M – $90.3M | $15.0M (0%) | valued on company size | 102 | flat | D | 13% |
| 1 Sep 2026 | $15.0M | $2.49M – $90.3M | $15.0M (0%) | valued on company size | 102 | flat | D | 13% |
| 1 Oct 2026 | $16.2M | $2.69M – $97.4M | $16.2M (0%) | valued on company size | 110 | flat | D | 0% |
| 24 Oct 2026 | $16.2M | $2.69M – $97.4M | $16.2M (0%) | valued on company size | 110 | flat | D | 0% |
Key facts about Zennya Health
- Founded
- 2015
- Headquarters
- Makati, Philippines
- Employees
- about 109 +6% in a year
- Total raised
- $1.0M
- Funding rounds
- 1
- Last round
- Seed May 2021
Zennya Health was founded in 2015 by David Foote.
Zennya Health funding history
Zennya Health has 1 funding round on record, from May 2021 to May 2021, $1.0M in total. None disclosed a valuation.
Seed 26 May 2021
With Day One Capital, Foxmont Capital Partners, Ignite House of Innovation.
$1.0M
Zennya Health investors
3 investors have backed Zennya Health.
- Day One Capital
- Ignite House of Innovation
What Zennya Health does
Zennya Health works in home health care, with 12 recorded offerings and customers in healthcare.
zennya, Inc., known as Zennya Health, is a Philippine company that operates as a medical clinic, wellness center, home health care provider, and massage therapist. The company delivers healthcare services such as laboratory tests, vaccinations, IV treatments, and virtual doctor consultations, as well as wellness and corporate health services including workplace vaccinations and return-to-work solutions. Zennya Health also provides medical logistics and technology solutions, including a mobile workforce, temperature-controlled equipment, and an online platform for appointment booking and medical record access. The company serves individuals, businesses, insurance providers, hospitals, laboratories, and hotels, and is ISO certified for data privacy and security.
Description from Veridion's company data.
Products and services
- Primary Care Delivery Services
- Virtual Doctor Consultation Services
- Lab Test Administration Services
- Vaccination Administration Services
- IV Therapy Administration Services
- Medicine Delivery Services
- Medical Massage Therapy Services
- Digital Health Record Management Services
- Corporate Health Services
- Home Health Care Services
- Mobile Health App Development
- Medical Institution Collaboration Services
Markets
- Healthcare
Certifications
- HIPAA compliant
- GDPR compliant
- Data Privacy Act of 2012 compliant
Business model
- Business-to-Business
- Business-to-Consumer
- Service Provider
- Healthcare
Industry codes (NAICS)
- 621610 Home Health Care Services 50% match
- 621511 Medical Laboratories 20% match
- 492210 Local Messengers and Local Delivery 15% match
- 621399 Offices of All Other Miscellaneous Health Practitioners 15% match
Questions about Zennya Health
What is Zennya Health worth?
Valuation $16.2M (range $2.69M to $97.4M), as of 24 Oct 2026.
Has Zennya Health raised money?
Zennya Health has 1 funding round on record, from May 2021 to May 2021, $1.0M in total. None disclosed a valuation.
Who has invested in Zennya Health?
Day One Capital, Foxmont Capital Partners and Ignite House of Innovation.
How many people work at Zennya Health?
About 109, up 6% over the last year. Headcount grew from 45 in Jan 2021 to 110 in Sep 2026.
What does Zennya Health do?
Zennya Health works in home health care, with 12 recorded offerings and customers in healthcare. Its main offerings are primary care delivery services, virtual doctor consultation services and lab test administration services.
When was Zennya Health founded, and where is it based?
Zennya Health was founded in 2015 and is based in Makati, Philippines. It has about 109 employees, up 6% over the last year.